1. Market Research
  2. > Biotechnology
  3. > Biomaterial Market Trends
  4. > Orthobiologics: Global Market Prospects 2012-2022

Orthobiologics: Global Market Prospects 2012-2022

  • March 2012
  • -
  • Visiongain
  • -
  • 123 pages

Report Details

Our new report Orthobiologics: Global Market Prospects 2012-2022 covers the trends in the orthobiologics market, a promising segment of the orthopaedic sector. The orthobiologics market will see significant growth during the period 2012-2022. Growth will be driven primarily by the increasing prevalence of arthritic conditions such as, osteoarthritis and osteoporosis. In addition, an increase in demand for minimally invasive products that offer improved comfort and durability will further drive growth of this market. Technological advancements in the field of orthobiologics have seen innovations such as liquid allografts and bone glues that not only repair fractured bone but also provide mechanical support for the healing process. This trend in technological advancements will continue during the forecast period and will also be a key factor that will sustain growth of the orthobiologics market. According to our latest pharma report - the global orthobiologics market will be worth $8.4bn by 2016.

The largest sector in orthobiologics in 2010 was bone grafts, accounting for 41.6% of the global market. Market growth in this sector is driven by the demand to develop bone graft substitutes as an alternative to using autograft bone, which has reported to have been associated with a number of complications such as, immunogenic rejection, infection, nerve injury and bleeding. There is also a limited supply of this type of bone graft. For these reasons, patient demand will be driven by the search for adequate alternatives such as allografts and synthetic bone grafts. This will fuel growth in the demand of these products, strengthening the marketing position of the bone grafts sector during the forecast period.

Orthobiologics: Global Market Prospects 2012-2022 also examines the size and value of leading national/regional markets. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period. The report also analyses the challenges facing the sector critically, including the safety issues. The report is developed through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses and a review of companies and leading products.

Why you should buy Orthobiologics: Global Market Prospects 2012-2022

In this report, you will receive the following benefits in particular:
• You will receive our assessment of the market for orthobiologics in 2010, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall orthobiologics market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - bone grafts, growth factors and stem cells - from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national/regional markets (US, Japan, Europe, India and China), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the orthobiologics market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the infusion pumps market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the orthobiologics market from 2012 onwards
• You will see what will stimulate and restrain the market from 2012
• You will discover the unmet needs in the market, driving the growth from 2012 onwards
• You will view expert opinion from our survey.

You can order this report today

Anybody with an interest in the orthobiologics market should gain valuable information and insight from this new study by Visiongain, which analyses one o

Table Of Contents

Orthobiologics: Global Market Prospects 2012-2022
Table of Contents

1. Executive Summary
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to Report

2. Introduction to Orthobiologics
2.1 Orthobiology
2.2 Types of Orthobiologics
2.3 Bone Grafts
2.3.1 Autograft
2.3.2 Allograft
2.3.3 Other Types of Bone Grafts
2.4 Growth Factors (GFs)
2.4.1 GF Proteins
2.4.2 Bone Morphogenetic Proteins (BMPs)
2.5 Stem Cells
2.6 The Potential of Orthobiologics

3. The Orthobiologics Market, 2010-2022
3.1 The Global Medical Devices Market, 2010
3.2 The Global Orthopaedic Devices Market, 2010
3.2.1 Orthopaedic Devices Market Trends, 2010
3.3 The Global Orthobiologics Market, 2010
3.4 Orthobiologics Market Forecast, 2011-2022
3.5 Orthobiologics Market Trends, 2012-2022
3.5.1 Increasing Use of Bone Graft Materials
3.5.2 Patient Demographics
3.5.3 Huge Potential for Growth Factors and Stem Cell Therapy

4. The Bone Grafts Market, 2010-2022
4.1 Bone Grafting
4.1.1 Bone Tissue
4.1.2 Biological Mechanism of Bone Grafting
4.2 Bone Grafts Market, 2010
4.3 Bone Grafts Market Forecast, 2011-2022
4.4 Bone Grafts Market Trends, 2012-2022
4.4.1 Spinal Fusion Procedures to Drive Bone Graft Usage
4.4.2 Increasing Demand for Bone Graft Substitutes

5. The Growth Factors Market, 2010-2022
5.1 Growth Factors
5.1.1 Wound Healing and The Role of Growth Factors
5.2 Bone Morphogenetic Proteins (BMP)
5.3 The BMP Market in 2010: Products and Companies
5.4 Growth Factors Market Forecast, 2011-2022
5.5 Growth Factors Market Trends, 2012-2022
5.5.1 Use in Spinal Fusion Procedures
5.5.2 Increasing Preference for BMPs

6. The Stem Cells Market, 2010-2022
6.1 Stem Cells
6.2 Stem Cell Therapy for Orthopaedics, 2010
6.3 Stem Cells Market Forecast, 2011-2022
6.4 Stem Cells Market Trends, 2012-2022

7. Leading Companies in The Orthobiologics Market, 2010
7.1 Intensively Competitive Market
7.2 Leading Companies in the Orthobiologics Market, 2010
7.3 Medtronic
7.3.1 Sales and Recent Performance Analysis, 2010 Spinal Sector
7.3.2 Medtronic's Orthobiologic Products
7.3.3 Acquisition of Otseotech
7.4 Genzyme
7.4.1 Sales and Recent Performance Analysis, 2010
7.4.2 Genzyme's Orthobiologic Products
7.4.3 Genzyme Enter Huge Japanese Market
7.5 Stryker
7.5.1 Sales and Recent Performance Analysis, 2010
7.5.2 Financial Analysis By Sector Medical And Surgical Orthopaedic Implants
7.5.3 Stryker's Orthobiologic Products Allografts Synthetics
7.5.4 Orthovita Inc. Acquisition To Strengthen Orthobiologic Portfolio
7.6 Integra Life Sciences
7.6.1 Sales and Recent Performance Analysis, 2010
7.6.2 Integra Life Sciences' Orthobiologic Products
7.6.3 New Product to Strengthen Advanced Orthobiologics Portfolio
7.7 Wright Medical
7.7.1 Sales and Recent Performance Analysis, 2010
7.7.2 Wright Medical's Orthobiologic Products
7.7.3 Cost Restructuring Plan Aims to Foster Future Growth
7.8 AAP Implantate
7.8.1 Sales and Recent Performance Analysis, 2010
7.8.2 AAP Implantate's Orthobiologic Products
7.9 Other Companies
7.10 Zimmer
7.10.1 Sales and Recent Performance Analysis, 2010
7.10.2 Zimmer's Orthobiologic Products
7.10.3 Asia-Pacific Expansion

8. Leading National Orthobiologic Markets, 2010
8.1 Regional Breakdown of The Global Orthobiologics Market, 2010
8.2 The Global Orthobiologics Market: Regional Forecast, 2011-2022
8.3 The US Market
8.4 The European Market
8.4.1 Germany and France
8.4.2 Italy
8.4.3 Spain
8.4.4 U.K
8.5 The Japanese Market
8.6 The Indian Market
8.7 The Chinese Market

9. SWOT Analysis of the Orthobiologics Market, 2012
9.1 Orthobiologics: Industry Trends
9.2 Stre

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

North American Orthobiologics Market by Type, by End-User - Analysis and Forecast to 2019

North American Orthobiologics Market by Type, by End-User - Analysis and Forecast to 2019

  • $ 2 650
  • Industry report
  • March 2015
  • by Micro Market Monitor

The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market. The high demand from end-use ...

World Collagen and HA-Based Biomaterials Industry

World Collagen and HA-Based Biomaterials Industry

  • $ 4 950
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Collagen and HA-Based Biomaterials in US$ Thousands by the following Product Segments: Collagen-based Biomaterials (Urinary Incontinence, Corneal Shields, ...



  • $ 7 495
  • Industry report
  • April 2015
  • by iData Research, Inc.

The loss of bone can cause discomfort and prevent patients from receiving dental implants. Bone grafting procedures using bone graft substitutes (BGS) are performed to repair bone loss. Bone grafting can ...

Download Unlimited Documents from Trusted Public Sources

Nanomaterial Statistics in Europe

  • April 2015
    186 pages
  • Nanomaterial  


  • Europe  



View report >

Biomaterials Industry in China

  • March 2015
    4 pages
  • Biomaterials  

  • China  

View report >

Biomaterials Industry in China

  • February 2015
    4 pages
  • Biomaterials  

  • China  

View report >

Related Market Segments :


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.